Synopsys Q3 Revenue Up 42.4% as AI Chip Complexity Feeds EDA Leader

Synopsys posted fiscal Q3 revenue of $2.48 billion, up 42.4% year over year, and raised full-year guidance across revenue, earnings and free cash flow. The EDA software leader now guides to full-year non-GAAP EPS of $15.04 to $15.10, replacing the initial range of $14.32 to $14.40. Shares have still fallen 9.81% over the past month.

The company sits at a choke point in the AI chip supply chain. Nearly every advanced AI chip gets designed, verified and simulated on software from a small group of vendors, and Synopsys leads that group. Whichever chipmaker wins the AI race, the winner's designs run through tools like these. Synopsys takes a toll on that work.

Why does AI complexity help Synopsys?

AI chips keep getting harder to build. Multi-die architectures, advanced packaging and heat management all add engineering hours, and those hours run on Synopsys tools.

On the fiscal Q3 call, management said AI design starts have continued accelerating while non-AI design starts stabilized over the last two quarters. NVIDIA held 4,821,717 Synopsys shares worth $2,150,823,302 as of June 30, 2026. That stake ties the most important AI chip designer directly to its toolmaker.

What does the quarter change for the numbers?

Three things stand out.

• Growth and guidance. Fiscal Q3 non-GAAP EPS of $3.91 beat the $3.6733 consensus. The Ansys acquisition inflates the revenue comparison, so the core business deserves separate tracking. Management expects double-digit organic EDA revenue growth for full-year 2026.
• Cash generation. Current free cash flow guidance is roughly $2.6 billion after Q3, replacing the previous February outlook of roughly $1.9 billion. The third quarter alone produced $746 million.
• The moat. Synopsys won more than 95% of PCIe 7 opportunities and has more than 100 cumulative die-to-die design wins. Its Factory 2 custom IP model adds royalties on top of licensing, tying Synopsys to hyperscaler custom silicon for years.

The valuation picture splits in two. At a forward P/E of about 25x, the stock trades well below its trailing multiple. The trailing multiple of 83x looks ugly because of acquisition amortization.

How does Synopsys compare with Cadence?

Cadence Design Systems is the name most readers reach for first, and it runs a fine business. The numbers still favor Synopsys on scale.

Cadence carries a market value of $90.995 billion and guides fiscal 2026 revenue to $6.387 billion to $6.417 billion, with operating cash flow of approximately $2.0 billion. Synopsys trades at $88.14 billion while guiding to $9.690 billion to $9.740 billion in revenue and about $2.6 billion in free cash flow. Synopsys offers a larger revenue base and more cash for a smaller market value.

What are the risks?

The Ansys deal left Synopsys with approximately $10 billion of total debt. Amortization of acquired intangible assets runs about $403.6 million per quarter and weighs on GAAP earnings.

Export rules matter more. Guidance assumes no further changes to export control restrictions or Entity List restrictions, and the company depends on a relatively small number of large customers.

Management keeps chipping away at the debt. Synopsys repaid $3.46 billion of long-term debt in the first half of fiscal 2026, paid off term loans earlier than planned and finished Q3 with $3.606 billion in cash. Synopsys pays no dividend, so shareholder returns depend on that cash compounding inside the business.

What comes next?

Several catalysts are already on the calendar.

• Multiphysics Fusion, the first joint Synopsys-Ansys product, should start contributing to EDA growth in 2027.
• Management remains committed to $400 million in synergies by year four after the acquisition.
• The board refilled a $2.0 billion buyback authorization.

Over the past ten years, the stock returned 671.34%. The long-term logic is simple. Every advanced AI chip of the next decade needs design software before it ever reaches a fab, and Synopsys sells that software.